Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis.

Susceptibility to autoimmune hepatitis is associated with the HLA-DR3 and DR4 haplotypes, but which genes are directly involved in the pathogenesis, has not been established. Low levels of complement component C4 and elevated frequencies of C4 null allotypes have been described in patients, suggesting that the C4 genes, which are closely linked with the HLA loci, may play a role. We therefore examined restriction fragment length polymorphisms in the C4 and 21-hydroxylase genes, and determined HLA-A and B phenotypes, and HLA-DR, DQ and DP genotypes in a large series of Caucasoid patients with autoimmune hepatitis and matched controls. A DNA deletion of the C4A gene and the 21-hydroxylase A pseudogene was found to be present in 50% of patients compared to 23% of controls (Pc < 0.005, relative risk = 3.3). This increase, however, appears to be due to linkage disequilibrium with HLA-DR52a which was most strongly associated with the disease. Complete C4A deficiency, determined by homozygosity for the deletion increased the risk to 18.1 (16% versus 1%, Pc < 0.005), suggesting an additional role for C4 in disease susceptibility. C4 deletions were associated with an increased mortality and tendency to relapse whilst on treatment but did not correlate with age of onset of disease. Our data suggest that MHC-encoded susceptibility to autoimmune hepatitis is polygenic, involving the HLA-DR genes plus other loci, and C4 deficiency may be a marker of disease susceptibility and/or severity.

[1]  C. Rittner,et al.  Coeliac disease and C4A*QO: an association secondary to HLA-DR3. , 2008, Tissue antigens.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  Roger Williams,et al.  Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis , 1994, Hepatology.

[4]  C. Toze,et al.  Early-onset autoimmune hepatitis is associated with a C4A gene deletion. , 1993, Gastroenterology.

[5]  H. Inoko,et al.  HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. , 1992, Gastroenterology.

[6]  D. Vergani,et al.  Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. , 1992, Arthritis and rheumatism.

[7]  R. Vaughan,et al.  HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. , 1992, Human immunology.

[8]  J. Trowsdale,et al.  COMPLEXITY IN THE MAJOR HISTOCOMPATIBILITY COMPLEX , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[9]  R. Wiesner,et al.  Prognostic features and role of liver transplantation in severe corticosteroid‐treated autoimmune chronic active hepatitis , 1992, Hepatology.

[10]  M. Manns,et al.  HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. , 1991, Gastroenterology.

[11]  A. Eddleston,et al.  The Natural Course and Heterogeneity of Autoimmune-Type Chronic Active Hepatitis , 1991, Seminars in liver disease.

[12]  Roger Williams,et al.  Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1‐B8‐DR3 are independent risk factors , 1991, Hepatology.

[13]  P. Donaldson,et al.  HLA‐DRB AND DQB TYPING BY A COMBINATION OF SEROLOGY, RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS AND OLIGONUCLEOTIDE PROBING , 1991, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[14]  D. Vergani,et al.  T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis , 1990, The Lancet.

[15]  M. Manns,et al.  The human hepatic asialoglycoprotein receptor is a target antigen for liver‐infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis , 1990, Hepatology.

[16]  K. Tokunaga,et al.  Lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. , 1990, The Journal of rheumatology.

[17]  U. Treichel,et al.  Autoantibodies to human asialoglycoprotein receptor in autoimmune‐type chronic hepatitis , 1990, Hepatology.

[18]  P. Schneider,et al.  Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and for gene conversion at the C4B locus , 1990, The Journal of experimental medicine.

[19]  D. Vergani,et al.  Liver membrane-specific T cell clones in autoimmune chronic active hepatitis (aCAH) , 1989 .

[20]  S. Serjeantson,et al.  Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. , 1987, The Journal of rheumatology.

[21]  M. Walport,et al.  Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. , 1987, Clinical and experimental immunology.

[22]  R. Wright,et al.  PERSISTENT MEASLES VIRUS GENOME IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1987, The Lancet.

[23]  I. Dunham,et al.  Molecular characterization of the HLA‐linked steroid 21‐hydroxylase B gene from an individual with congenital adrenal hyperplasia. , 1987, The EMBO journal.

[24]  R. Campbell,et al.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.

[25]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[26]  K. Belt,et al.  Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region. , 1985, The EMBO journal.

[27]  D. Vergani,et al.  GENETICALLY DETERMINED LOW C4: A PREDISPOSING FACTOR TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1985, The Lancet.

[28]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[29]  S. Poppema,et al.  CELLULAR AND HUMORAL IMMUNE-REACTIONS IN CHRONIC ACTIVE LIVER-DISEASE .1. LYMPHOCYTE SUBSETS IN LIVER BIOPSIES OF PATIENTS WITH UNTREATED IDIOPATHIC AUTOIMMUNE HEPATITIS, CHRONIC ACTIVE HEPATITIS-B AND PRIMARY BILIARY-CIRRHOSIS , 1982 .

[30]  K. Whaley,et al.  Complement activation in chronic liver disease. , 1982, Clinical and experimental immunology.

[31]  J. Schifferli,et al.  Inhibition of immune precipitation by complement. , 1980, Clinical and experimental immunology.

[32]  I. Mackay,et al.  HLA associations with autoimmune-type chronic active hepatitis: Identification of B8-DRw3 haplotype by family studies , 1980 .

[33]  C. Alper,et al.  Inherited structural polymorphism of the fourth component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Daha,et al.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. , 1979, The Journal of clinical investigation.

[35]  D. Jewell,et al.  Immune complexes in acute and chronic liver disease. , 1978, Clinical and experimental immunology.

[36]  K. Anderson,et al.  Significance of serum complement levels in chronic liver disease. , 1972, Gastroenterology.

[37]  J. Kurtz,et al.  Raised antibody titres to measles and rubella viruses in chronic active hepatitis. , 1972, Lancet.

[38]  R. Snyderman,et al.  Neutralization of Sensitized Virus by the Fourth Component of Complement , 1969, Science.

[39]  M. Ashburner.  A Laboratory manual , 1989 .

[40]  M. Baur,et al.  Reference Tables of Two-Locus Haplotype Frequencies for All MHC Marker Loci , 1984 .

[41]  N. Farid,et al.  Reduced C4 in HLA-B8 positive patients with Graves' disease. , 1981, Human heredity.

[42]  H. Ochs,et al.  Genetic analysis of C4 deficiency. , 1981, The Journal of clinical investigation.